Does Rallies show Form 4 insider transactions for XOMA?

Yes. Rallies tracks XOMA insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.

Is XOMA research on Rallies investment advice?

No. Rallies provides research, data, and educational context for XOMA. It does not provide personalized investment advice.

XOMA (XOMA Royalty Corporation Common Stock) Stock Analysis - Insider Trades

XOMA Royalty Corporation Common Stock (XOMA) is a publicly traded Healthcare sector company. As of May 21, 2026, XOMA trades at $41.97 with a market cap of $522.21M and a P/E ratio of 25.40. XOMA moved +1.04% today. Year to date, XOMA is +57.70%; over the trailing twelve months it is +57.82%. Its 52-week range spans $18.35 to $42.81. Analyst consensus is neutral with an average price target of $42.67. Rallies surfaces XOMA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading XOMA stock inside the company?

Recent XOMA insider activity includes Hughes Owen bought 100.00K, BURNS THOMAS M. sold 4.30K, BURNS THOMAS M. sold 15, BURNS THOMAS M. sold 15, and Sitko Bradley bought 2.00K. Rallies tracks insider transaction dates, shares, prices, and estimated values.

XOMA Key Metrics

Key financial metrics for XOMA
Metric	Value
Price	$41.97
Market Cap	$522.21M
P/E Ratio	25.40
EPS	$1.65
Dividend Yield	0.00%
52-Week High	$42.81
52-Week Low	$18.35
Volume	1
Avg Volume	0
Revenue (TTM)	$48.55M
Net Income	$33.81M
Gross Margin	0.00%

Recent XOMA Insider Trades

Hughes Owen bought 100.00K (~$2.50M) on Dec 4, 2025.
BURNS THOMAS M. sold 4.30K (~$154.71K) on Sep 22, 2025.
BURNS THOMAS M. sold 15 (~$553.95) on Sep 22, 2025.
BURNS THOMAS M. sold 15 (~$552.15) on Sep 22, 2025.
Sitko Bradley bought 2.00K (~$50.78K) on Jun 30, 2025.

Latest XOMA News

Investors Challenge Proposed XOMA’s $39-Per-Share Deal with Ligand — May 14, 2026
XOMA Royalty Declares $0.53906 and $0.52344 Preferred Stock Dividends — Mar 18, 2026
XOMA Royalty Reports $50M Cash Receipts, 68% Royalty Growth and $16M Buyback — Mar 18, 2026
XOMA Royalty Completes $4.2913 Tender Offer for 70% of Generation Bio — Feb 9, 2026

XOMA Analyst Consensus

4 analysts cover XOMA: 0 strong buy, 1 buy, 3 hold, 0 sell, 0 strong sell. Consensus rating is neutral. Average price target: $42.67.

Common questions about XOMA

Who is trading XOMA stock inside the company?: Recent XOMA insider activity includes Hughes Owen bought 100.00K, BURNS THOMAS M. sold 4.30K, BURNS THOMAS M. sold 15, BURNS THOMAS M. sold 15, and Sitko Bradley bought 2.00K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for XOMA?: Yes. Rallies tracks XOMA insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is XOMA research on Rallies investment advice?: No. Rallies provides research, data, and educational context for XOMA. It does not provide personalized investment advice.